Bevacizumab (HLX04)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bevacizumab (HLX04), covering 2024-10-17 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC) [Phase 2, Phase 3]